Process Guide
The FDA Import Alert Removal Petition
A closer look at the document that gets a firm off an import alert — what a removal petition contains, how it's formatted and submitted, what happens after you file, and the deficiencies that most often send petitions back.
The Short Version
What Is an Import Alert Removal Petition?
It's the formal written request — with evidence — asking FDA to remove your firm or product from an import alert. There's no fill-in form; the petition is a documented package you submit to FDA's Division of Import Operations (DIO) making the case that the conditions behind the alert are resolved and future shipments will comply. FDA reviews the totality of the evidence and either grants removal (or Green List addition) or, more often than people expect, returns the petition with deficiencies to correct. Getting the contents and format right the first time is what separates a months-shorter outcome from a stalled one.
Inside the Petition
What Goes Into a Removal Petition
- Firm & Alert Details
- The petitioning firm's name and address, the specific import alert number, and the entry numbers of any released shipments. File one petition per import alert.
- Root Cause Analysis
- A documented investigation identifying the source of the violation — the foundation the rest of the petition builds on.
- Corrective & Preventive Actions
- What was fixed and what's now in place to prevent recurrence, with supporting records, updated plans, and dates.
- Supporting Evidence
- Third-party lab analyses, audit reports, certificates of analysis, corrected labeling, and registration proof — each attached as a separate, clearly titled PDF.
- Clean-Shipment Record
- For many alerts, documentation of the required consecutive, commercial-size, non-violative entries released by FDA.
- Letter of Authorization
- If an agent or consultant files on the firm's behalf, a signed, dated letter on company letterhead stating the representative's authority.
A useful detail: third-party lab packages already submitted to FDA through ITACS generally don't need to be re-attached to the petition — but the entries still need to be referenced. Knowing what to include and what to omit keeps the package clean.
Filing It
How the Petition Is Submitted
-
Assemble the Package
Compile the narrative and evidence per FDA's Regulatory Procedures Manual (RPM 9-8) and the Guidance section of your specific alert, each exhibit a separate, descriptively named PDF.
-
Submit to DIO
File with FDA's Division of Import Operations — by email to the address FDA designates for import-alert petitions, or by mail. Submit one petition per alert; there is no FDA filing fee.
-
Receive Acknowledgement
FDA sends an acknowledgement in the form you filed, including a case number and an assigned FDA contact. Your product stays on the Red List while the petition is reviewed.
-
Review, Then Decision
FDA reviews the totality of the evidence. If satisfied, it issues a letter confirming removal or Green List addition and closes the case. If not, it typically returns the petition with deficiencies to address.
Why Petitions Come Back
The Deficiencies That Cause Delays
The usual failure points
- Thin corrective-action documentation. Skipping a real root cause analysis, or describing fixes without evidence they were implemented, is a leading reason petitions are returned.
- Non-commercial or non-consecutive shipments. Sample-size entries, split containers, or a violative shipment breaking the run don't satisfy the requirement.
- Shipments that weren't actually detained. Entries that slipped through without detention under the alert don't count toward the required run.
- Missing or mislabeled exhibits. A single missing certificate of analysis or a disorganized package can stall review; each exhibit should be a clearly named PDF.
- Wrong format or wrong channel. Not following RPM 9-8 or the alert's Guidance, sending status-check emails that slow review, or filing to a prior reviewer instead of the correct channel all cost time.
Where we fit: we coordinate the sampling and independent testing that build your clean-shipment evidence. The petition drafting and regulatory strategy are led by a regulatory consultant or counsel — our sister service FDA Registration Assistance focuses on that side, so the testing and the petition can move together.
Related
Related Guides
How to Get Off an Import Alert
The bigger picture: release vs. removal, the five-shipment rule, and the overall path.
Read the guide LabsFDA Private Laboratory Testing
The per-shipment testing and analytical packages behind the clean-shipment evidence.
Read the guide HubDetention Help Center
All the detention guides in one place — notice, timeline, testing, cost, and removal.
Browse guidesBuilding Toward a Petition?
Send the Alert — We'll Coordinate the Evidence
Send your import alert number and situation. We'll coordinate the sampling and testing that build your clean-shipment record and connect the petition side, so the pieces come together instead of stalling apart.
Urgent detention matters receive priority intake review.
FDA Detention Sampling is an independent private company. We are not affiliated with, endorsed by, or part of the U.S. Food and Drug Administration. This guide is general information about the FDA import alert removal process and is not legal advice; requirements and submission procedures vary by alert and can change, and the Guidance section of your specific import alert and FDA's Regulatory Procedures Manual control. Sampling, laboratory testing, documentation, and coordination services do not guarantee FDA release, admissibility, acceptance of laboratory results, removal from any import alert, or any specific regulatory outcome. FDA makes the final decision on removal.